Photochemistry and Photobiology · 1995 · 11 citations · 32 references
Medicinal ChemistrySupramolecular PhotochemistryPhotochemistryPhotodynamic TherapyMedicineMechanistic PhotochemistryPhotobiologyPhototoxicityRadiopharmaceutical TherapyPicket Fence PorphyrinBiophotonicsDermatologyO-substituted TetraphenylporphyrinsPhotosensitizersPharmacologyRadiation OncologyNuclear MedicineHealth Sciences
From a structurally distinct set of o-substituted tetraphenylporphyrins, the picket fence porphyrin (PFP), 3,1-meso-tetrakis(o-propionamidophenyl)porphyrin (3,1-TPro) has been selected as a potential candidate for use in the photodynamic therapy (PDT) of cancer. In this report, the time-dependent tissue distribution of 14C-labeled 3,1-TPro is described along with the results of various treatment regimens. The tissue distribution of radiolabeled 3,1-TPro is comparable to that of other porphyrin photosensitizers with the advantage of being most effective at 4 h and being cleared rapidly from most tissues. The results of the various treatment regimen experiments, as well as other studies, indicate that the 3,1-TPro mechanism of action is similar to that of other photosensitizers, but may include some minor differences. The conclusion is that 3,1-TPro and other PFP offer a class of effective photosensitizers that may be exploited for their structural versatility, straightforward synthesis leading to a compound of high purity and known structure, and stability (both in terms of shelf-life and in vivo metabolism) as potential candidates for PDT.
32
Photoradiation therapy for the treatment of malignant tumors.
Thomas J. Dougherty, J. Kaufman, Abraham Goldfarb et al. · PubMed · 1978 · 1.5K citations
Richard L. Lipson, Edward J. Baldes, Arthur M. Olsen · JNCI Journal of the National Cancer Institute · 1961 · 628 citations
PHOTODYNAMIC THERAPY OF MALIGNANT TUMOURS
Ivan Diamond, AntonyF. Mcdonagh, CharlesB. Wilson et al. · The Lancet · 1972 · 419 citations